# Crane NXT, Co.: financial statements, quarterly

CXT · NYSE · CIK 25445 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cxt.md) · [Financials](/companies/cxt/financials.md) · [Filings](/companies/cxt/filings.md) · [Insiders](/companies/cxt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cxt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [353](/filings/0001628280-24-045745.md) | [357 d](/filings/0000025445-26-000009.md) | [314](/filings/0001628280-25-023195.md) | [371](/filings/0000025445-25-000083.md) | [404](/filings/0000025445-25-000095.md) | [399 d](/filings/0000025445-26-000009.md) | [330](/filings/0000025445-26-000017.md) | [404](/filings/0000025445-26-000034.md) | [445](/filings/0000025445-25-000095.md) | [477 d](/filings/0000025445-26-000009.md) | [388](/filings/0000025445-26-000017.md) | [493](/filings/0000025445-26-000034.md) |
| Cost of revenue | $m | [187](/filings/0001628280-24-045745.md) | [191 d](/filings/0000025445-26-000009.md) | [161](/filings/0001628280-25-023195.md) | [210](/filings/0000025445-25-000083.md) | [232](/filings/0000025445-25-000095.md) | [219 d](/filings/0000025445-26-000009.md) | [190](/filings/0000025445-26-000017.md) | [236](/filings/0000025445-26-000034.md) | [253](/filings/0000025445-25-000095.md) | [275 d](/filings/0000025445-26-000009.md) | [232](/filings/0000025445-26-000017.md) | [285](/filings/0000025445-26-000034.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [85.8](/filings/0001628280-24-045745.md) | [92.6 d](/filings/0000025445-26-000009.md) | [94.3](/filings/0001628280-25-023195.md) | [93.3](/filings/0000025445-25-000083.md) | [96.3](/filings/0000025445-25-000095.md) | [102 d](/filings/0000025445-26-000009.md) | [103](/filings/0000025445-26-000017.md) | [114](/filings/0000025445-26-000034.md) | [107](/filings/0000025445-25-000095.md) | [117 d](/filings/0000025445-26-000009.md) | [131](/filings/0000025445-26-000017.md) | [136](/filings/0000025445-26-000034.md) |
| Operating income | $m | [79.7](/filings/0001628280-24-045745.md) | [72.4 d](/filings/0000025445-26-000009.md) | [55.4](/filings/0001628280-25-023195.md) | [67.6](/filings/0000025445-25-000083.md) | [75.0](/filings/0000025445-25-000095.md) | [70.8 d](/filings/0000025445-26-000009.md) | [37.3](/filings/0000025445-26-000017.md) | [47.9](/filings/0000025445-26-000034.md) | [81.9](/filings/0000025445-25-000095.md) | [79.6 d](/filings/0000025445-26-000009.md) | [22.2](/filings/0000025445-26-000017.md) | [68.9](/filings/0000025445-26-000034.md) |
| Interest expense | $m | not reported | not reported | [9.9](/filings/0001628280-25-023195.md) | [12.4](/filings/0000025445-25-000083.md) | [13.4](/filings/0000025445-25-000095.md) | not reported | [11.5](/filings/0000025445-26-000017.md) | [16.4](/filings/0000025445-26-000034.md) | [16.2](/filings/0000025445-25-000095.md) | not reported | [17.8](/filings/0000025445-26-000017.md) | [21.0](/filings/0000025445-26-000034.md) |
| Income tax | $m | [16.0](/filings/0001628280-24-045745.md) | [11.9 d](/filings/0000025445-26-000009.md) | [8.9](/filings/0001628280-25-023195.md) | [13.8](/filings/0000025445-25-000083.md) | [16.2](/filings/0000025445-25-000095.md) | [3.4 d](/filings/0000025445-26-000009.md) | [6.4](/filings/0000025445-26-000017.md) | [7.8](/filings/0000025445-26-000034.md) | [15.7](/filings/0000025445-25-000095.md) | [6.0 d](/filings/0000025445-26-000009.md) | [2.4](/filings/0000025445-26-000017.md) | [11.7](/filings/0000025445-26-000034.md) |
| Net income | $m | [51.9](/filings/0001628280-24-045745.md) | [49.5 d](/filings/0000025445-26-000009.md) | [37.8](/filings/0000025445-25-000095.md) | [41.6](/filings/0000025445-25-000095.md) | [47.1](/filings/0000025445-25-000095.md) | [57.6 d](/filings/0000025445-26-000009.md) | [21.7](/filings/0000025445-26-000017.md) | [24.9](/filings/0000025445-26-000034.md) | [50.5](/filings/0000025445-25-000095.md) | [48.0 d](/filings/0000025445-26-000009.md) | [6.4](/filings/0000025445-26-000017.md) | [35.4](/filings/0000025445-26-000034.md) |
| Diluted EPS | $ per share | [0.90](/filings/0001628280-24-045745.md) | not reported | [0.66](/filings/0001628280-25-023195.md) | [0.72](/filings/0000025445-25-000083.md) | [0.81](/filings/0000025445-25-000095.md) | not reported | [0.38](/filings/0000025445-26-000017.md) | [0.43](/filings/0000025445-26-000034.md) | [0.87](/filings/0000025445-25-000095.md) | not reported | [0.11](/filings/0000025445-26-000017.md) | [0.61](/filings/0000025445-26-000034.md) |
| Basic EPS | $ per share | [0.91](/filings/0001628280-24-045745.md) | not reported | [0.66](/filings/0001628280-25-023195.md) | [0.73](/filings/0000025445-25-000083.md) | [0.82](/filings/0000025445-25-000095.md) | not reported | [0.38](/filings/0000025445-26-000017.md) | [0.43](/filings/0000025445-26-000034.md) | [0.88](/filings/0000025445-25-000095.md) | not reported | [0.11](/filings/0000025445-26-000017.md) | [0.61](/filings/0000025445-26-000034.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [229](/filings/0001628280-23-037049.md) | [227](/filings/0001628280-25-006754.md) | [221](/filings/0001628280-24-021706.md) | [176](/filings/0001628280-24-035654.md) | [165](/filings/0001628280-24-045745.md) | [166](/filings/0000025445-26-000009.md) | [174](/filings/0001628280-25-023195.md) | [153](/filings/0000025445-25-000083.md) | [182](/filings/0000025445-25-000095.md) | [234](/filings/0000025445-26-000034.md) | [228](/filings/0000025445-26-000017.md) | [231](/filings/0000025445-26-000034.md) |
| Current assets | $m | [625](/filings/0001628280-23-037049.md) | [644](/filings/0001628280-25-006754.md) | [629](/filings/0001628280-24-021706.md) | [632](/filings/0001628280-24-035654.md) | [631](/filings/0001628280-24-045745.md) | [643](/filings/0000025445-26-000009.md) | [677](/filings/0001628280-25-023195.md) | [743](/filings/0000025445-25-000083.md) | [771](/filings/0000025445-25-000095.md) | [853](/filings/0000025445-26-000034.md) | [1,014](/filings/0000025445-26-000017.md) | [981](/filings/0000025445-26-000034.md) |
| Total assets | $m | [2,094](/filings/0001628280-23-037049.md) | [2,129](/filings/0001628280-25-006754.md) | [2,099](/filings/0001628280-24-021706.md) | [2,388](/filings/0001628280-24-035654.md) | [2,411](/filings/0001628280-24-045745.md) | [2,387](/filings/0000025445-26-000009.md) | [2,429](/filings/0001628280-25-023195.md) | [2,918](/filings/0000025445-25-000083.md) | [2,918](/filings/0000025445-25-000095.md) | [3,116](/filings/0000025445-26-000034.md) | [3,640](/filings/0000025445-26-000017.md) | [3,595](/filings/0000025445-26-000034.md) |
| Current liabilities | $m | [313](/filings/0001628280-23-037049.md) | [334](/filings/0001628280-25-006754.md) | [297](/filings/0001628280-24-021706.md) | [527](/filings/0001628280-24-035654.md) | [456](/filings/0001628280-24-045745.md) | [562](/filings/0000025445-26-000009.md) | [564](/filings/0001628280-25-023195.md) | [619](/filings/0000025445-25-000083.md) | [610](/filings/0000025445-25-000095.md) | [569](/filings/0000025445-26-000034.md) | [763](/filings/0000025445-26-000017.md) | [693](/filings/0000025445-26-000034.md) |
| Total liabilities | $m | [1,222](/filings/0001628280-23-037049.md) | [1,165](/filings/0001628280-25-006754.md) | [1,135](/filings/0001628280-24-021706.md) | [1,398](/filings/0001628280-24-035654.md) | [1,340](/filings/0001628280-24-045745.md) | [1,322](/filings/0000025445-26-000009.md) | [1,322](/filings/0001628280-25-023195.md) | [1,741](/filings/0000025445-25-000083.md) | [1,705](/filings/0000025445-25-000095.md) | [1,860](/filings/0000025445-26-000034.md) | [2,382](/filings/0000025445-26-000017.md) | [2,309](/filings/0000025445-26-000034.md) |
| Long-term debt | $m | [708](/filings/0001628280-23-037049.md) | [640](/filings/0001628280-25-006754.md) | [640](/filings/0001628280-24-021706.md) | [639](/filings/0001628280-24-035654.md) | [638](/filings/0001628280-24-045745.md) | [541](/filings/0000025445-26-000009.md) | [541](/filings/0001628280-25-023195.md) | [862](/filings/0000025445-25-000083.md) | [834](/filings/0000025445-25-000095.md) | [1,004](/filings/0000025445-26-000034.md) | [1,259](/filings/0000025445-26-000017.md) | [1,260](/filings/0000025445-26-000034.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [6.6](/filings/0001628280-23-037049.md) | [4.6](/filings/0001628280-25-006754.md) | [30.2](/filings/0001628280-24-021706.md) | [220](/filings/0001628280-24-035654.md) | [155](/filings/0001628280-24-045745.md) | [210](/filings/0000025445-26-000009.md) | [264](/filings/0001628280-25-023195.md) | [267](/filings/0000025445-25-000083.md) | [248](/filings/0000025445-25-000095.md) | [135](/filings/0000025445-26-000034.md) | [250](/filings/0000025445-26-000017.md) | [194](/filings/0000025445-26-000034.md) |
| Shareholders' equity | $m | [873](/filings/0001628280-24-045745.md) | [964](/filings/0001628280-25-023195.md) | [964](/filings/0001628280-25-023195.md) | [990](/filings/0001628280-24-045745.md) | [1,071](/filings/0000025445-25-000095.md) | [1,065](/filings/0000025445-26-000017.md) | [1,107](/filings/0000025445-26-000017.md) | [1,175](/filings/0000025445-25-000083.md) | [1,214](/filings/0000025445-25-000095.md) | [1,253](/filings/0000025445-26-000034.md) | [1,239](/filings/0000025445-26-000017.md) | [1,266](/filings/0000025445-26-000034.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [103 d](/filings/0001628280-24-045745.md) | [78.5 d](/filings/0000025445-26-000009.md) | [9.5](/filings/0001628280-25-023195.md) | [56.8 d](/filings/0000025445-25-000083.md) | [66.7 d](/filings/0000025445-25-000095.md) | [81.1 d](/filings/0000025445-26-000009.md) | [(19.1)](/filings/0000025445-26-000017.md) | [62.8 d](/filings/0000025445-26-000034.md) | [92.0 d](/filings/0000025445-25-000095.md) | [106 d](/filings/0000025445-26-000009.md) | [(14.0)](/filings/0000025445-26-000017.md) | [86.7 d](/filings/0000025445-26-000034.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [7.9 d](/filings/0001628280-24-045745.md) | [7.9 d](/filings/0000025445-26-000009.md) | [9.1](/filings/0001628280-25-023195.md) | [9.2 d](/filings/0000025445-25-000083.md) | [9.1 d](/filings/0000025445-25-000095.md) | [9.2 d](/filings/0000025445-26-000009.md) | [9.7](/filings/0000025445-26-000017.md) | [9.8 d](/filings/0000025445-26-000034.md) | [9.7 d](/filings/0000025445-25-000095.md) | [9.8 d](/filings/0000025445-26-000009.md) | [10.3](/filings/0000025445-26-000017.md) | [10.4 d](/filings/0000025445-26-000034.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [56.7](/filings/0001628280-23-037049.md) | [56.7](/filings/0001628280-24-021706.md) | [57.4](/filings/0001628280-24-035654.md) | [57.5](/filings/0001628280-24-045745.md) | [57.7](/filings/0001628280-25-023195.md) | [57.8](/filings/0000025445-25-000083.md) | [57.8](/filings/0000025445-25-000095.md) | [57.9](/filings/0000025445-26-000017.md) | [57.9](/filings/0000025445-26-000034.md) | [58.0](/filings/0000025445-25-000095.md) | [58.0](/filings/0000025445-26-000017.md) | [58.0](/filings/0000025445-26-000034.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 57,561,304 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0000025445-26-000034.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.